Crestor and Cefzil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Crestor (rosuvastatin calcium) and Cefzil (cefprozil). Common drug interactions include chronic kidney disease among females and adjustment disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Crestor and Cefzil. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Crestor?

Crestor has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 149,761 Crestor users. Check the latest studies of Crestor.

What is Cefzil?

Cefzil has active ingredients of cefprozil. It is often used in sinusitis. eHealthMe is studying from 1,106 Cefzil users. Check the latest studies of Cefzil.



On Jul, 28, 2026

15 people who take Crestor and Cefzil together, and have interactions are studied.

Crestor and Cefzil drug interactions.

What are the common drug interactions of Crestor and Cefzil, by gender? *:

female:

  1. Chronic kidney disease
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Renal failure (kidney dysfunction)
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  7. Atypical femur fracture
  8. Bone disorder
  9. Chest pain
  10. Femur fracture

male:

  1. Adjustment disorder
  2. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  3. Cough
  4. Dizziness
  5. Dizziness postural
  6. Dysphonia (speech disorder attributable to a disorder of phonation)
  7. Fatigue (feeling of tiredness)
  8. Gait disturbance
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Graft complication

What are the common drug interactions of Crestor and Cefzil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Bipolar disorder (mood disorder)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Renal cell carcinoma (a kidney cancer)
  5. Renal failure (kidney dysfunction)
  6. Single functional kidney (single kidney)
  7. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

50-59:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Nephrogenic anaemia (anaemia due to kidney disease)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Fall
  4. Femur fracture
  5. Fracture delayed union (delayed cure of broken bone)
  6. Fracture displacement
  7. Low turnover osteopathy (slow removal of old bone and its replacement by new bone)
  8. Muscular weakness (muscle weakness)
  9. Pain
  10. Pathological fracture (broken bone caused by disease)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 60.00%
  2. Pain: 8 people, 53.33%
  3. Infection: 6 people, 40.00%
  4. Stress And Anxiety: 6 people, 40.00%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 33.33%
  6. High Blood Pressure: 5 people, 33.33%
  7. Cough: 4 people, 26.67%
  8. Depression: 4 people, 26.67%
  9. Anaemia (lack of blood): 4 people, 26.67%
  10. Blood Pressure Abnormal: 4 people, 26.67%

* Approximation only. Some reports may have incomplete information.

Do you take Crestor and Cefzil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Crestor and Cefzil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Crestor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefzil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Crestor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefzil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rosuvastatin calcium and cefprozil (the active ingredients of Crestor and Cefzil, respectively), and Crestor and Cefzil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: